The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from $2.89 billion a year earlier.
Dow Jones Newswires: Novartis sales and profit drop, but backs 2022 guidance
By
admin
#article_normal, #backs, #C&E Industry News Filter, #Content Types, #Corporate, #Corporate/Industrial News, #DOW, #drop, #Earnings, #Factiva Filters, #Financial Performance, #Guidance, #Healthcare, #Healthcare/Life Sciences, #industrial news, #Jones, #life sciences, #Newswires, #Novartis, #Pharmaceuticals, #Profit, #sales, #Sales Figures